New technologies promise sharper artificial vision for blind people
The Paris-based company Pixium Vision is testing the device in five people who have the photoreceptor-destroying disease macular degeneration. At last week’s meeting, Palanker presented videos showing that participants who had been implanted with the prosthesis for about 1 year could recognize objects on a table and read printed or on-screen letters. The artificial vision is good enough to make out the title of a book, Palanker says, though not the words on its pages. His team is now working to shrink the photodiodes—creating finer pixels and sharper vision—without losing too much signal strength.
Pixium Vision: “For biotechs, Euronext becomes a Third World market”
(BFM Bourse) – The decline of biotech intensifies, Pixium now drop more than 30% over the last five sessions and 40% over a month, with no particular relevance. A movement whose financial director admits he does not understand the outcome, which leads him to question the future of the sector but also future of Euronext.
French Tech: The 2019 Ranking Of The 100 Most Inventive Startups
Pixium ranked #7 of the top 100 most innovative start-ups in France by Forbes (and ranked #1 Life Science company on the list).